Skip to Main Content

Faculty Directory

Back to
Faculty Directory
Sanjay Chandrasekaran, M.D.

Sanjay Chandrasekaran, M.D.

Titles and Appointments

Assistant Professor

Endowed Title
Eugene P. Frenkel, M.D. Scholar in Clinical Medicine
School
Medical School
Department
Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Sanjay Chandrasekaran, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of the Division of Hematology and Oncology. He specializes in hematology and oncology, with a focus on melanoma, advanced skin cancer, and soft tissue and bone sarcomas.

    Dr. Chandrasekaran holds a bachelor's degree in biochemistry from the University of Pennsylvania. He earned his medical degree at the University of Washington School of Medicine. He completed joint residency and advanced fellowship training in internal medicine, hematology, and medical oncology through the physician-scientist pathway at Emory University and its Winship Cancer Institute.

    Certified by the American Board of Internal Medicine in medical oncology, Dr. Chandrasekaran joined the UT Southwestern faculty in 2021.

    Dr. Chandrasekaran is a member of several professional associations, including the American Society of Clinical Oncology and the American Medical Association.

    Dr. Chandrasekaran has published numerous academic articles, delivered multiple presentations, and served as a grant reviewer for the When Everyone Survives Leukemia Research Foundation.

    During fellowship training, Dr. Chandrasekaran received a Conquer Cancer Foundation of ASCO Merit Award and was the recipient of the 2020 Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group’s Paul Carbone, MD Fellowship Award.

  • Education
    Medical School
    University of Washington (2014)
    Residency
    Emory University School of Medicine (2016), Internal Medicine
    Fellowship
    Emory University School of Medicine - Emory Winship Cancer Institute (2021), Hematology Oncology
  • Publications

    Star Featured Publications

    Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States.
    Chandrasekaran S, Ling YL, Tang J, Melanoma Res 2024 Jul
    STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.
    Somatilaka BN, Madana L, Sadek A, Chen Z, Chandrasekaran S, McKay RM, Le LQ, J Clin Invest 2024 Mar
    Gene Expression Analysis Links Autocrine Vasoactive Intestinal Peptide and ZEB1 in Gastrointestinal Cancers.
    Rao IH, Waller EK, Dhamsania RK, Chandrasekaran S, Cancers (Basel) 2023 Jun 15 13
    Passenger Pathogens on Physicians.
    Funk CR, Ravindranathan S, Matelski A, Zhang H, Taylor C, Chandrasekaran S, Arellano M, Langston AA, Joseph N, Waller EK, Am J Infect Control 2022 Oct
    Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-d and -?.
    Chandrasekaran S, Funk CR, Kleber T, Paulos CM, Shanmugam M, Waller EK, Front Immunol 2021 12 718621
    20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment.
    Chandrasekaran S, Lawson DH, Ann Transl Med 2020 Jun 8 12 776
    Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
    Chandrasekaran S, Sasaki M, Scharer CD, Kissick HT, Patterson DG, Magliocca KR, Seykora JT, Sapkota B, Gutman DA, Cooper LA, Lesinski GB, Waller EK, Thomas SN, Kotenko SV, Boss JM, Moreno CS, Swerlick RA, Pollack BP, Mol Cancer Res 2019 12 17 12 2395-2409
    Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
    Ju M, Kao GD, Steinmetz D, Chandrasekaran S, Keefe SM, Guzzo TJ, Christodouleas JP, Hahn SM, Dorsey JF, Cancer Biol Ther 2014 Jun 15 6 683-7
    Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.
    Macarthur KM, Kao GD, Chandrasekaran S, Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM, Dorsey JF, Cancer Res 2014 Apr 74 8 2152-9
    18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
    Chandrasekaran S, Hollander A, Xu X, Benci JL, Davis JJ, Dorsey JF, Kao G, ScientificWorldJournal 2013 2013 796029
  • Honors & Awards
    • Paul Carbone, MD Fellowship Award
      ECOG-ACRIN Cancer Research Group (2020)
    • Merit Award
      Conquer Cancer Foundation of the American Society of Clinical Oncology (2019)
    • Elkin Fellowship Award
      Winship Cancer Institute of Emory University (2017-2018)
    • Postdoctoral Fellow
      National Institutes of Health / National Research Service Award (NIH / NRSA) (2017-2020)
  • Professional Associations/Affiliations
    • American Medical Association
    • American Society of Clinical Oncology